Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin for the Treatment of Cough in Idiopathic Pulmonary Fibrosis
NCT02173145Completed
- Sponsor
- Insel Gruppe
- Start
- Aug 2014
- Primary completion
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of azithromycin in idiopathic pulmonary fibrosis (IPF) and cough (2 arms), sponsored by Insel Gruppe. Primary endpoint: Number of patients with a subjective response to treatment at 3 months. Started Aug 2014; status: completed.
02
Drugs
azithromycin
03
Conditions
idiopathic pulmonary fibrosis (IPF)cough
Beyond the preview
Go deeper on NCT02173145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02173145.